Molecular and epigenetic characterization and study of tetraploidies in drug-resistant epileptic patients of the temporal lobe
Funding period: 2018-2021
Funding Agency: Proyecto de Investigación en Salud Instituto de Salud Carlos III
Principal Investigator: Dr. Mª Carmen Ovejero Benito y Dr. Cristina Torres
Pharmacogenetics of Brodalumab
Funding period: 2019-2022
Funding Agency: Leo Pharma
Principal Investigator: Mª Carmen Ovejero Benito
